Indicators
Indicators
Value
Direction
MACD(12,26,9)
-3.764
Neutral
RSI(14)
51.128
Neutral
STOCH(KDJ)(9,3,3)
54.647
Neutral
ATR(14)
7.842
Low Volatility
CCI(14)
-47.321
Neutral
Williams %R
34.492
Buy
TRIX(12,20)
0.262
Sell
StochRSI(14)
46.974
Buy
Search
Danaher Corp
DHRAdd to Watchlist
192.380USD
+13.240+7.39%
Close 07-23 16:00（ET）Quotes delayed by 15 min
135.22BMarket Cap
37.05P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+7.39%
5 Days
-6.16%
1 Month
+7.49%
6 Months
-18.14%
Year to Date
-15.96%
1 Year
-2.78%
Key Figures
186.390Open
192.870High
11.55MVolume
37.05P/E TTM
20.56P/E Dynamic
1.360Dividend TTM
1.64%Turnover Ratio
179.140Prev. Close
184.000Low
1.24BTurnover
34.68P/E Static
2.57P/B
0.71%Div Yield TTM
4.52%ROA
242.80052wk High
1.06Volume Ratio
3.90BNet Profit
702.90MShares
5.1926EPS TTM
0.81Beta
7.08%ROE
160.93052wk Low
4.95%Amplitude
57.64%Gross Margin
135.22BMarket Cap
-3.27Reward/Risk
1.58%Risk Rate
TradingKey Stock Score of Danaher Corp
Currency: USD Updated: 2026-07-23Key Insights
Danaher Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 9 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 226.84.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Danaher Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Danaher Corp Highlights
StrengthsRisks
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 20.13%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 20.13%.
Undervalued
The company’s latest PE is 37.07, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 594.48M shares, decreasing 0.66% quarter-over-quarter.
Held by Al Gore
Star Investor Al Gore holds 7.97M shares of this stock.
Analyst Rating
Based on
28
analysts
Buy
Current Rating
226.837
Target Price
+26.72%
Upside Space
Danaher Corp News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
28
analysts
Buy
Current Rating
226.837
Target Price
+26.72%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Danaher Corp
DHR
28
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Indicators
Moving Average
Indicators
Value
Direction
MA5
191.118
Buy
MA10
195.965
Sell
MA20
194.926
Sell
MA50
183.974
Buy
MA100
186.258
Buy
MA200
204.022
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Danaher Corp Info
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Ticker SymbolDHR
CompanyDanaher Corp
CEOBlair (Rainer M)
Websitehttps://www.danaher.com/
Shareholders
Related Instruments
-1.77%
+8.73%
+0.22%
-1.08%
+3.22%
-2.54%
+0.18%
+1.33%
-2.54%
+0.46%
+1.44%
+1.48%
-0.68%
-0.78%
-0.99%
-0.14%
+4.72%
+3.15%
+0.12%Popular Instruments
FAQs
What is the current price of Danaher Corp (DHR)?
The current price of Danaher Corp (DHR) is 192.38.
What is the symbol of Danaher Corp?
The ticker symbol of Danaher Corp is DHR.
What is the 52-week high of Danaher Corp?
The 52-week high of Danaher Corp is 242.80.
What is the 52-week low of Danaher Corp?
The 52-week low of Danaher Corp is 160.93.
What is the market capitalization of Danaher Corp?
The market capitalization of Danaher Corp is 135.22B.
Is Danaher Corp (DHR) currently rated as Buy, Hold, or Sell?
According to analysts, Danaher Corp (DHR) has an overall rating of Buy, with a price target of 226.84.
What is the Earnings Per Share (EPS TTM) of Danaher Corp (DHR)?
The Earnings Per Share (EPS TTM) of Danaher Corp (DHR) is 5.07.